Filing Details
- Accession Number:
- 0001140361-23-046976
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-10-04 17:15:20
- Reporting Period:
- 2023-10-02
- Accepted Time:
- 2023-10-04 17:15:20
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1764013 | Immunovant Inc. | IMVT | Pharmaceutical Preparations (2834) | D0 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1635088 | Ltd. Sciences Roivant | 7Th Floor 50 Broadway London X0 SW1H 0DB | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.0001 Par Value Per Share | Acquisiton | 2023-10-02 | 4,473,684 | $38.00 | 78,279,015 | No | 4 | A | Direct | |
| Common Stock, $0.0001 Par Value Per Share | Acquisiton | 2023-10-02 | 1,526,316 | $38.00 | 79,805,331 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | P | Direct |
Billionaire Hedge Funds
